Integer Holdings designs and manufactures advanced medical devices for global healthcare OEMs, serving diverse therapeutic markets.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Integer Holdings designs and manufactures advanced medical devices for global healthcare OEMs, serving diverse therapeutic markets.
Wondering if Okta at around US$82.77 is a bargain, fairly priced, or still looking expensive? This guide walks through the numbers so you can judge the value for yourself. The stock has climbed about 22.9% over the past month, even though returns are roughly flat year to date and down 35.0% over the past year and 65.3% over five years. Recent headlines around Okta have focused on security incidents and product reliability, which can affect how investors think about long term adoption and...
Is OKTA a good stock to buy? We came across a bullish thesis on Okta, Inc. on Compounding Your Wealth’s Substack by Sergey. In this article, we will summarize the bulls’ thesis on OKTA. Okta, Inc.’s share was trading at $77.64 as of April 21st. OKTA’s trailing and forward P/E were 57.83 and 19.84 respectively according to Yahoo Finance. Okta, Inc. operates as […]
A number of stocks jumped in the morning session after strong earnings and upbeat forecasts from several peers boosted the broader software sector.
An analyst firm just put its stamp of approval on cybersecurity leader CrowdStrike (NASDAQ:CRWD). Mizuho upgraded CRWD stock to Outperform from Neutral and lifted its price target to $520 from $490, citing improving channel checks and the company’s pole position in AI security. The call lands as cybersecurity stocks regain momentum. CrowdStrike stock trades at $455 ... Mizuho Upgrades CrowdStrike With a $520 Price Target: Is AI Security the Next Mega-Trade?
According to the average brokerage recommendation (ABR), one should invest in Okta (OKTA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?